3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
2
Autistic Disorder
2
Uterine Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Intellectual Disability
1
Hamartoma Syndrome, Multiple
1
Gastroenteropancreatic Neuroendocrine Tumors
1
Gallbladder Neoplasms
1
Adenoma, Islet Cell
1
Interventions
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Intellectual Disability
×
Everolimus
×
Clear all
NCT01730209
2015-05-05
RAPIT
Erasmus Medical Center
Phase 2/3
Unknown
60 enrolled